Market Research Logo

Anesthetic Effect - Pipeline Review, H2 2015

Anesthetic Effect - Pipeline Review, H2 2015

Summary

Global Markets Direct’s, ‘Anesthetic Effect - Pipeline Review, H2 2015’, provides an overview of the Anesthetic Effect’s therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Anesthetic Effect, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Anesthetic Effect and special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global therapeutic landscape of Anesthetic Effect
  • The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
  • The report reviews key players involved in the therapeutics development for Anesthetic Effect and enlists all their major and minor projects
  • The report summarizes all the dormant and discontinued pipeline projects
  • A review of the Anesthetic Effect products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
  • Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • A detailed assessment of monotherapy and combination therapy pipeline projects
  • Coverage of the Anesthetic Effect pipeline on the basis of target, MoA, route of administration and molecule type
  • Latest news and deals relating related to pipeline products
Reasons to buy
  • Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop strategic initiatives by understanding the focus areas of leading companies
  • Identify and understand important and diverse types of therapeutics under development for Anesthetic Effect
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Devise corrective measures for pipeline projects by understanding Anesthetic Effect pipeline depth and focus of Indication therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline


Introduction
Global Markets Direct Report Coverage
Anesthetic Effect Overview
Therapeutics Development
Pipeline Products for Anesthetic Effect - Overview
Pipeline Products for Anesthetic Effect - Comparative Analysis
Anesthetic Effect - Therapeutics under Development by Companies
Anesthetic Effect - Therapeutics under Investigation by Universities/Institutes
Anesthetic Effect - Pipeline Products Glance
Late Stage Products
Clinical Stage Products
Early Stage Products
Unknown Stage Products
Anesthetic Effect - Products under Development by Companies
Anesthetic Effect - Products under Investigation by Universities/Institutes
Anesthetic Effect - Companies Involved in Therapeutics Development
Advicenne Pharma
Biolab Sanus Farmaceutica Ltda.
Drawbridge Pharmaceuticals Pty Ltd
Jiangsu Hengrui Medicine Co., Ltd.
Juniper Pharmaceuticals, Inc.
Laboratoires Thea S.A.
Lipicard Technologies Limited
Merck & Co., Inc.
NanoMedex Pharmaceuticals, Inc.
Paion AG
Phosphagenics Limited
Physica Pharma SAS
Proteus SA
Sphaera Pharma Pvt. Ltd.
Taiwan Liposome Company, Ltd.
The Medicines Company
Anesthetic Effect - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Combination Products
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
(lidocaine hydrochloride + phenylephrine hydrochloride + tropicamide) - Drug Profile
Product Description
Mechanism of Action
R&D Progress
(tetracaine hydrochloride + oxymetazoline hydrochloride) - Drug Profile
Product Description
Mechanism of Action
R&D Progress
ABP-700 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
ADV-6209 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
alphaxalone - Drug Profile
Product Description
Mechanism of Action
R&D Progress
bupivacaine hydrochloride - Drug Profile
Product Description
Mechanism of Action
R&D Progress
carboetomidate - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Gabafol - Drug Profile
Product Description
Mechanism of Action
R&D Progress
HSK-3486 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
lidocaine hydrochloride ER - Drug Profile
Product Description
Mechanism of Action
R&D Progress
LT-1121 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
LT-1123 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
methoxycarbonyl carboetomidate - Drug Profile
Product Description
Mechanism of Action
R&D Progress
methoxycarbonyl etomidate - Drug Profile
Product Description
Mechanism of Action
R&D Progress
neosaxitoxin - Drug Profile
Product Description
Mechanism of Action
R&D Progress
PB-5109 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
PHY-301 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
propofol - Drug Profile
Product Description
Mechanism of Action
R&D Progress
propofol microemulsion - Drug Profile
Product Description
Mechanism of Action
R&D Progress
propofol-DM - Drug Profile
Product Description
Mechanism of Action
R&D Progress
remimazolam - Drug Profile
Product Description
Mechanism of Action
R&D Progress
remimazolam - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Small Molecules to Inhibit NMDA Receptor for Anaesthesia - Drug Profile
Product Description
Mechanism of Action
R&D Progress
sugammadex sodium - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Anesthetic Effect - Recent Pipeline Updates
Anesthetic Effect - Dormant Projects
Anesthetic Effect - Discontinued Products
Anesthetic Effect - Product Development Milestones
Featured News & Press Releases
Oct 12, 2015: Remimazolam Posters at Anesthesiology 2015
Aug 11, 2015: Paion Starts EU Phase III Study With Remimazolam In The Indication General Anesthesia
Jun 15, 2015: Juniper Pharmaceuticals Announces First Patient Enrolled in Phase II Study of COL-1077 as an Acute-Use Anesthetic for Minimally-Invasive Gynecologic Procedures
Jun 08, 2015: PAION Announces Initiation Of Second U.S. Phase 3 Clinical Trial Of Remimazolam For Procedural Sedation During Bronchoscopy
Apr 28, 2015: FDA Declines To Approve Merck’s Bridion
Mar 13, 2015: Merck Provides Regulatory Update on Investigational Medicine Sugammadex Injection
Feb 10, 2015: Drawbridge Pharmaceuticals granted Notice of Allowance for divisional patent in the United States
Nov 05, 2014: Paion's Partner Ono Decides Not To File For Regulatory Approval Of REMIMAZOLAM In Japan And Will Return Its REMIMAZOLAM Rights For Japan To Paion
Oct 14, 2014: Invitation To Conference Call Of Paion About The Project Status Of Remimazolam In Japan
Oct 10, 2014: Paion Expects Ono’S Remimazolm Decision On Filing In Japan In November 2014
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Number of Products under Development for Anesthetic Effect, H2 2015
Number of Products under Development for Anesthetic Effect - Comparative Analysis, H2 2015
Number of Products under Development by Companies, H2 2015
Number of Products under Development by Companies, H2 2015 (Contd...1)
Number of Products under Investigation by Universities/Institutes, H2 2015
Comparative Analysis by Late Stage Development, H2 2015
Comparative Analysis by Clinical Stage Development, H2 2015
Comparative Analysis by Early Stage Development, H2 2015
Comparative Analysis by Unknown Stage Development, H2 2015
Products under Development by Companies, H2 2015
Products under Development by Companies, H2 2015 (Contd...1)
Products under Investigation by Universities/Institutes, H2 2015
Anesthetic Effect - Pipeline by Advicenne Pharma, H2 2015
Anesthetic Effect - Pipeline by Biolab Sanus Farmaceutica Ltda., H2 2015
Anesthetic Effect - Pipeline by Drawbridge Pharmaceuticals Pty Ltd, H2 2015
Anesthetic Effect - Pipeline by Jiangsu Hengrui Medicine Co., Ltd., H2 2015
Anesthetic Effect - Pipeline by Juniper Pharmaceuticals, Inc., H2 2015
Anesthetic Effect - Pipeline by Laboratoires Thea S.A., H2 2015
Anesthetic Effect - Pipeline by Lipicard Technologies Limited, H2 2015
Anesthetic Effect - Pipeline by Merck & Co., Inc., H2 2015
Anesthetic Effect - Pipeline by NanoMedex Pharmaceuticals, Inc., H2 2015
Anesthetic Effect - Pipeline by Paion AG, H2 2015
Anesthetic Effect - Pipeline by Phosphagenics Limited, H2 2015
Anesthetic Effect - Pipeline by Physica Pharma SAS, H2 2015
Anesthetic Effect - Pipeline by Proteus SA, H2 2015
Anesthetic Effect - Pipeline by Sphaera Pharma Pvt. Ltd., H2 2015
Anesthetic Effect - Pipeline by Taiwan Liposome Company, Ltd., H2 2015
Anesthetic Effect - Pipeline by The Medicines Company, H2 2015
Assessment by Monotherapy Products, H2 2015
Assessment by Combination Products, H2 2015
Number of Products by Stage and Target, H2 2015
Number of Products by Stage and Mechanism of Action, H2 2015
Number of Products by Stage and Route of Administration, H2 2015
Number of Products by Stage and Molecule Type, H2 2015
Anesthetic Effect Therapeutics - Recent Pipeline Updates, H2 2015
Anesthetic Effect - Dormant Projects, H2 2015
Anesthetic Effect - Dormant Projects (Contd...1), H2 2015
Anesthetic Effect - Discontinued Products, H2 2015
List of Figures
Number of Products under Development for Anesthetic Effect, H2 2015
Number of Products under Development for Anesthetic Effect - Comparative Analysis, H2 2015
Number of Products under Development by Companies, H2 2015
Comparative Analysis by Late Stage Development, H2 2015
Comparative Analysis by Clinical Stage Development, H2 2015
Comparative Analysis by Early Stage Products, H2 2015
Assessment by Monotherapy Products, H2 2015
Number of Products by Targets, H2 2015
Number of Products by Stage and Targets, H2 2015
Number of Products by Mechanism of Actions, H2 2015
Number of Products by Stage and Mechanism of Actions, H2 2015
Number of Products by Routes of Administration, H2 2015
Number of Products by Stage and Routes of Administration, H2 2015
Number of Products by Stage and Molecule Types, H2 2015

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report